Interventional Cardiology Devices Market

Interventional Cardiology Devices Market Size by Product (Coronary Stents, Angioplasty Balloons, Catheters, Plaque Modification Devices, Structural Heart Devices, and Others), End-User (Clinics and Ambulatory Surgical Centers (ASCs) and Hospitals), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13873
  • Published Date: Dec, 2023
  • Pages: 237
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global Interventional Cardiology Devices market was estimated at USD 18.01 billion in 2022, which is projected to expand at a CAGR of 7.59% from 2023 to 2032. Cardiovascular diseases (CVD) are a cluster of diseases affecting the heart, blood vessels, and conduction system. The fundamental pathology is atherosclerosis, which is the build-up of cholesterol, fats, and other materials on and in the walls of blood vessel. By an obstructive method, which aggravates over time and amid certain lifestyle aspects, atherosclerosis lowers blood flow to the heart, prompting strokes and myocardial infarction. Some of the common cardiovascular diseases are stroke, coronary heart disease, rheumatic heart disease, angina, aortic aneurysm and dissection, peripheral arterial disease, congenital heart disease, and deep vein thrombosis.

Market Introduction:

Interventional cardiology is a field that detects and treats conditions of heart and blood vessels by employing small tubes known as catheters. These small tubes are put through the blood vessels of the patient. The use of catheters allows physicians to avoid performing open-heart surgical procedure. Still physicians achieve outcomes that can be lifesaving, like in case of treating a heart attack. Healthcare providers operating in this category of cardiology help individuals with coronary (heart) and vascular (blood vessel) disorders. They are also beneficial for patients who are affected with structural heart disorder. These diseases consist of septal defects and heart valve defects. Cardiac catheterization, balloon angioplasty, PCI (percutaneous coronary intervention), stent implantation, and atherectomy are a few of the most frequent interventional cardiology processes. Cardiac catheterization assesses the size, presence, and location of the plaque deposits in arteries, function of the heart valves, and vitality of the heart muscle. In cardiac catheterization, a catheter is injected into a blood vessel in the wrist or leg and smoothly guided toward the heart. Contrast dye is infused into arteries of the heart so that the cardiologist can outline the flow of blood through the arteries and the heart chambers. The objective of PCI (percutaneous coronary intervention), also called as angioplasty, is to open a coronary artery to reinstate flow of the blood. Percutaneous coronary intervention can be an arranged procedure to cure chronically insufficient blood flow to the heart or an emergency procedure for a heart attack patient. Balloon angioplasty enhances flow of blood to the heart. A catheter with a balloon at its tip is directed till the blocked artery. The balloon angioplasty procedure employs a specific pulverizing device to clear hardened blockages in coronary arteries. During a balloon angioplasty, atherectomy is often performed. After atherectomy or balloon angioplasty, a small mesh tube or metal coil known as a stent might be placed in the artery. The stent is positioned at the tip of a catheter, injected through a blood vessel in the wrist or leg, and pointed up to the heart, where it maintains newly opened arteries from collapsing.

Interventional Cardiology Devices Market Size

Get an overview of this study by requesting a free sample

Recent Development
  • TekniPlex Healthcare, which utilises advanced materials science expertise to help deliver better patient outcomes, will highlight its recently introduced PTA/PTCA Balloon Catheter Tubing for coronary and non-coronary angioplasty applications at Medtec Innovation Forum in December 2023.
  • In October 2023, Boston Scientific Corporation announced positive 12-month results from the pivotal AGENT IDE clinical trial of the AGENT Drug-Coated Balloon (DCB). Primary endpoint findings from this first clinical trial in the U.S. to evaluate the safety and effectiveness of using a DCB to treat coronary in-stent restenosis (ISR) were presented in a late-breaking clinical trial session at Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation. This trial met the primary endpoint of target lesion failure (TLF) at 12 months with the AGENT DCB demonstrating statistical superiority to uncoated balloon angioplasty (17.9% vs. 28.7%; P=0.006). These differences were mainly driven by significantly reduced rates of myocardial infarction related to the target vessel (TV-MI, or heart attack) and the need for a target lesion revascularization (TLR, or a repeated percutaneous coronary intervention) procedure.
  • In January 2023, the U.S. Food and Drug Administration (FDA) approved the Stellarex 0.035” OTW Drug-coated Angioplasty Balloon – P160049/S015, from Philips Image Guided Therapy Corp. The Stellarex 0.035” OTW Drug-coated Angioplasty Balloon (Stellarex 035 DCB) uses a drug-coated balloon to re-open blocked or narrowed arteries in the thigh and knee due to peripheral artery disease (PAD). The balloon is coated on its outer surface with the drug paclitaxel which may help prevent the arteries from narrowing again (restenosis).

Market Dynamics:


Rise in occurrence of cardiovascular disorders- CVDs (cardiovascular diseases) are the dominant cause of morbidity and mortality globally. Determining the general disease burden amid the young adults and youth is essential. Identifying the hazard factors linked with CVDs in this set of individuals will assist in formulating effective and directed prevention tactics. Currently, there are nearly 620 million persons living with circulatory and heart diseases around the world and this figure has been increasing as a result of changing lifestyle and an aging and rising population. Plaques (cholesterol deposits) in the heart arteries and inflammation are typically the root cause of coronary artery disorder. Indicators and symptoms of CAD (coronary artery disease) occur after the heart doesn't receive sufficient oxygen-rich blood. Every year nearly 60 million persons worldwide develop a circulatory or heart illness. Around 80 million females and 110 million males are living with coronary heart disorder worldwide. Around nine million people die due to coronary heart disease every year – in 2019 coronary heart disease was the world’s single largest killer. About 1 in 6 fatalities worldwide are triggered by coronary heart disorder. Prior to the coronavirus (COVID-19) pandemic, coronary heart disease was the prominent cause of death globally for around 30 years.


Increasing demand from developing regions- The prevalence of cardiovascular disorders has risen in populations of developing countries. A recent study has revealed that non-HDL and total cholesterol levels have expanded in developing regions, especially in south east and east Asia. non-HDL cholesterol was incriminated as a contributing factor in around 4 million deaths globally, according to a data published in 2017. Around half of these deaths occurred in south, southeast, and east Asia. Moreover, advancement in healthcare infrastructure in low- and middle-income countries, increasing awareness regarding ill effects of rise in cholesterol levels, substantial investments by government authorities to advance healthcare set-up, and increasing demand for advanced healthcare facilities is expected to boost the growth of interventional cardiology devices.


Frequent product recall The rising instances of product recall is presenting serious challenges for the interventional cardiology devices market. Maintaining quality and sterility is crucial for all the devices. Product recall hampers the growth of the market to a great extent.

Regional segmentation analysis:

The regions analysed for the market study include North America, South America, Europe, the Middle East, and Africa, and Asia Pacific. North America is the most significant market for interventional cardiology devices market, with a 38.59% market revenue share in 2022. Factors such as high awareness, availability of advanced healthcare infrastructure, presence of market leading companies in the region, increasing demand for preventive healthcare, and high spending capacity are expected to maintain the dominance of North America in the global interventional cardiology devices market.

North America Region Interventional Cardiology Devices Market Share in 2022 - 38.59%

Check the geographical analysis of this market by requesting a free sample

Product Segment Analysis

The product segment is divided into coronary stents, angioplasty balloons, catheters, plaque modification devices, structural heart devices, and others. Coronary stents have been further segmented into bare-metal stents (BMS), drug-eluting stents (DES), and bioresorbable stent (BRS). Angioplasty balloons have been further segmented into drug-eluting balloons, old/normal balloons, and scoring and cutting balloons. Catheters have been further segmented into guiding catheters, angiography catheters, and intravascular ultrasound (IVUS)/optical coherence tomography (OCT) catheters. Plaque modification devices have been further segmented into thrombectomy devices and atherectomy devices. The coronary stents product segment dominated, with a market share of around 39.57% in 2022. Increasing government initiatives, and high demand from developing countries is contributing to the high market share of coronary stents.

End-User Segment Analysis

The end-user segment is divided into clinics and ambulatory surgical centers (ASCs) and hospitals. The ambulatory surgical centers (ASCs) and hospitals segment dominated the end-user segment.

Some of the Key Market Players:
  • Medtronic
  • Abbott Laboratories
  • Terumo
  • Boston Scientific
  • B. Braun
  • Koninklijke Philips N.V.
  • Biosensors International
  • Meril Life Sciences
  • iVascular
  • Teleflex Medical
  • Becton, Dickinson and Company (BD)
  • Merit Medical Systems
  • Cardinal Health

Report Description:

Attribute Description
Market Size Revenue (USD Billion)
Market size value in 2022 USD 18.01 Billion
Market size value in 2032 USD 35.99 Billion
CAGR (2023 to 2032) 7.59%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Region The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
Segments Product, End User

Frequesntly Asked Questions

As per The Brainy Insights, the size of the interventional cardiology devices market was valued at USD 18.01 Billion in 2022 & USD 35.99 Billion by 2032.

Global interventional cardiology devices market is growing at a CAGR of 7.59% during the forecast period 2023-2032.

North America region emerged as the largest market for the interventional cardiology devices.

The rise in occurrence of cardiovascular disorders is a significant driving factor for the growth of the interventional cardiology devices market.

The increasing demand from developing regions is a significant opportunity for the growth of the interventional cardiology devices market.

Frequent product recall is a significant challenging factor for the growth of the interventional cardiology devices market.

Request Table of Content


This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global interventional cardiology devices market based on below mentioned segments:

Global Interventional Cardiology Devices by Product:

  • Coronary Stents
    • Bare-Metal Stents (BMS)
    • Drug-Eluting Stents (DES)
    • Bioresorbable Stent (BRS)
  • Angioplasty Balloons
    • Drug-Eluting Balloons
    • Old/Normal Balloons
    • Scoring and Cutting Balloons
  • Catheters
    • Guiding Catheters
    • Angiography Catheters
    • Intravascular Ultrasound (IVUS)/Optical Coherence Tomography (OCT) Catheters
  • Plaque Modification Devices
    • Thrombectomy Devices
    • Atherectomy Devices
  • Structural Heart Devices
  • Others

Global Interventional Cardiology Devices by End-User:

  • Clinics
  • Ambulatory Surgical Centers (ASCs) and Hospitals

Global Interventional Cardiology Devices by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa


Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:


Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights


Free Customization


Fortune 500 Clients


Free Yearly Update On Purchase Of Multi/Corporate License


Companies Served Till Date